Family history and APOE-4 genetic risk in Alzheimer's disease

Neuropsychol Rev. 2012 Sep;22(3):298-309. doi: 10.1007/s11065-012-9193-2. Epub 2012 Feb 23.

Abstract

Identifying risk factors for Alzheimer's disease, such as carrying the APOE-4 allele, and understanding their contributions to disease pathophysiology or clinical presentation is critical for establishing and improving diagnostic and therapeutic strategies. A first-degree family history of Alzheimer's disease represents a composite risk factor, which reflects the influence of known and unknown susceptibility genes and perhaps non-genetic risks. There is emerging evidence that investigating family history risk associated effects may contribute to advances in Alzheimer's disease research and ultimately clinical practice.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / genetics*
  • Alzheimer Disease / pathology
  • Alzheimer Disease / physiopathology
  • Apolipoprotein E4 / genetics*
  • Apolipoprotein E4 / physiology
  • Biomarkers / cerebrospinal fluid
  • Brain* / pathology
  • Brain* / physiopathology
  • Diffusion Tensor Imaging
  • Family
  • Functional Neuroimaging
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Magnetic Resonance Imaging
  • Neuroimaging
  • Phenotype
  • Positron-Emission Tomography
  • Risk Factors

Substances

  • Apolipoprotein E4
  • Biomarkers